Penetration of Endothelial Cell Coated Multicellular Tumor Spheroids by Iron Oxide Nanoparticles

被引:65
作者
Ho, Don N. [1 ,2 ]
Kohler, Nathan [2 ]
Sigdel, Aruna [2 ]
Kalluri, Raghu [3 ]
Morgan, Jeffrey R. [1 ]
Xu, Chenjie [2 ,4 ]
Sun, Shouheng [2 ]
机构
[1] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Harvard Univ, Sch Med, Dept Med,Beth Israel Deaconess Med Ctr, Dept Biol Chem & Mol Pharmacol,Harvard MIT Div Hl, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Harvard Stem Cell Inst,Harvard MIT,Div H, Cambridge, MA 02139 USA
关键词
iron oxide nanoparticles; tumstatin; tumor penetration; multicellular tumor spheroids; theranostic; magnetic; nanoparticle; imaging; drug delivery; anti-angiogenesis; CONTRAST AGENTS; DELIVERY; PERMEABILITY; TISSUE; GLIOMA;
D O I
10.7150/thno.3568
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Iron oxide nanoparticles are a useful diagnostic contrast agent and have great potential for therapeutic applications. Multiple emerging diagnostic and therapeutic applications and the numerous versatile parameters of the nanoparticle platform require a robust biological model for characterization and assessment. Here we investigate the use of iron oxide nanoparticles that target tumor vasculature, via the tumstatin peptide, in a novel three-dimensional tissue culture model. The developed tissue culture model more closely mimics the in vivo environment with a leaky endothelium coating around a glioma tumor mass. Tumstatin-iron oxide nanoparticles showed penetration and selective targeting to endothelial cell coating on the tumor in the three-dimensional model, and had approximately 2 times greater uptake in vitro and 2.7 times tumor neo-vascularization inhibition. Tumstatin provides targeting and therapeutic capabilities to the iron oxide nanoparticle diagnostic contrast agent platform. And the novel endothelial cell-coated tumor model provides an in vitro microtissue environment to evaluate nanoparticles without moving into costly and time-consuming animal models.
引用
收藏
页码:66 / 75
页数:10
相关论文
共 24 条
[1]   αvβ3 and αvβ5 integrin expression in glioma periphery [J].
Bello, L ;
Francolini, M ;
Marthyn, P ;
Zhang, JP ;
Carroll, RS ;
Nikas, DC ;
Strasser, JF ;
Villani, R ;
Cheresh, DA ;
Black, PM .
NEUROSURGERY, 2001, 49 (02) :380-389
[2]   Integrin Targeted Delivery of Chemotherapeutics [J].
Chen, Kai ;
Chen, Xiaoyuan .
THERANOSTICS, 2011, 1 :189-200
[3]   Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers [J].
Dreher, MR ;
Liu, WG ;
Michelich, CR ;
Dewhirst, MW ;
Yuan, F ;
Chilkoti, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :335-344
[4]   Spheroid-based drug screen: considerations and practical approach [J].
Friedrich, Juergen ;
Seidel, Claudia ;
Ebner, Reinhard ;
Kunz-Schughart, Leoni A. .
NATURE PROTOCOLS, 2009, 4 (03) :309-324
[5]   Spatio-temporal modeling of nanoparticle delivery to multicellular tumor spheroids [J].
Goodman, Thomas T. ;
Chen, Jingyang ;
Matveev, Konstantin ;
Pun, Suzie H. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (02) :388-399
[6]  
Goodman TT, 2007, INT J NANOMED, V2, P265
[7]  
Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3
[8]   Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles [J].
Hao, Rui ;
Xing, Ruijun ;
Xu, Zhichuan ;
Hou, Yanglong ;
Gao, Song ;
Sun, Shouheng .
ADVANCED MATERIALS, 2010, 22 (25) :2729-2742
[9]   pH-responsive endosomolytic pseudo-peptides for drug delivery to multicellular spheroids tumour models [J].
Ho, Vincent H. B. ;
Slater, Nigel K. H. ;
Chen, Rongjun .
BIOMATERIALS, 2011, 32 (11) :2953-2958
[10]   Tumstatin, an endothelial cell-specific inhibitor of protein synthesis [J].
Maeshima, Y ;
Sudhakar, A ;
Lively, JC ;
Ueki, K ;
Kharbanda, S ;
Kahn, CR ;
Sonenberg, N ;
Hynes, RO ;
Kalluri, R .
SCIENCE, 2002, 295 (5552) :140-143